82 results
424B3
SCLX
Scilex Holding Company
13 May 24
Prospectus supplement
4:18pm
Accounting Oversight Board requiring mandatory audit firm rotation;
reduced disclosure about our executive compensation arrangements in our periodic reports
424B3
SCLX
Scilex Holding Company
13 May 24
Prospectus supplement
4:15pm
Accounting Oversight Board requiring mandatory audit firm rotation;
reduced disclosure about our executive compensation arrangements in our periodic reports
424B3
SCLX
Scilex Holding Company
2 Apr 24
Prospectus supplement
5:20pm
and oversight activities such as implementing statutes through rulemaking, issuance of guidance, and review and approval of marketing applications … ability to exercise its regulatory authority. If these executive actions impose constraints on FDA’s ability to engage in oversight and implementation
424B3
SCLX
Scilex Holding Company
2 Apr 24
Prospectus supplement
5:19pm
delay, the FDA’s ability to engage in routine regulatory and oversight activities such as implementing statutes through rulemaking, issuance of guidance … constraints on FDA’s ability to engage in oversight and implementation activities in the normal course, our business, financial condition and results
POS AM
y7nfr3z9
27 Mar 24
Prospectus update (post-effective amendment)
5:30pm
POS AM
9eqz0hkgb uk
27 Mar 24
Prospectus update (post-effective amendment)
5:29pm
424B3
hnpm4dcjl22u60qs02
5 Mar 24
Prospectus supplement
4:20pm
424B3
g7p4f8ahy
5 Mar 24
Prospectus supplement
4:17pm
424B3
yd5iztak01qc xqd
5 Mar 24
Prospectus supplement
4:16pm
424B3
4csf73 w37g6nm5nv
5 Mar 24
Prospectus supplement
4:13pm
8-K
EX-1.1
pxrs6dly9w980eos7nbg
5 Mar 24
Scilex Holding Company Announces $10 Million Bought Deal Offering
4:12pm
424B3
fmmb 4sul
22 Dec 23
Prospectus supplement
4:43pm
424B3
cea14pw51t2drdcb8e
22 Dec 23
Prospectus supplement
4:36pm
424B3
sx93sassq7z0a0j
22 Dec 23
Prospectus supplement
4:33pm
424B3
aujrxi1umts
22 Dec 23
Prospectus supplement
4:28pm
424B3
zy6ueoxowvn
22 Dec 23
Prospectus supplement
4:23pm